ACQUISITION, Part I (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Jun. 25, 2012
ACQUISITION [Abstract]
Convertible price per share for outstanding eBio shares (in dollars per share)		$ 38.18
Revenue, Net, eBioscience specific	$ 37,011
Net Loss, eBioscience specific	8,941
Total purchase price		314,891
Business Acquisition, Cost of Acquired Entity, Acceleration of Stock Options	8,265	8,265
Business Acquisition, Cost of Acquired Entity, Purchase Price		306,626
Debt Instrument, 4.00% Interest Rate, Stated Percentage	4.00%	4.00%
Business Acquisition, Components of Cash Paid for Acquisition [Line Items]
Acquisition consideration		306,626
Share-based compensation expense	8,265	8,265
Total purchase price		314,891
Determination of Fair Value of Acquired Assets and Assumed Liabilities - Initial [Member]
ACQUISITION [Abstract]
Total purchase price		315,106
Business Acquisition, Cost of Acquired Entity, Acceleration of Stock Options		8,265
Business Acquisition, Cost of Acquired Entity, Purchase Price		306,841
Business Acquisition, Components of Cash Paid for Acquisition [Line Items]
Acquisition consideration		306,841
Share-based compensation expense		8,265
Total purchase price		315,106
Measurement Period Adjustments for Purchase Accounting [Member]
ACQUISITION [Abstract]
Total purchase price		(215)
Business Acquisition, Cost of Acquired Entity, Acceleration of Stock Options		0
Business Acquisition, Cost of Acquired Entity, Purchase Price		(215)
Business Acquisition, Components of Cash Paid for Acquisition [Line Items]
Acquisition consideration		(215)
Share-based compensation expense		0
Total purchase price		(215)
Determination of Fair Value of Acquired Assets and Assumed Liabilities- Final [Member]
ACQUISITION [Abstract]
Total purchase price		314,891
Business Acquisition, Cost of Acquired Entity, Acceleration of Stock Options		8,265
Business Acquisition, Cost of Acquired Entity, Purchase Price		306,626
Business Acquisition, Components of Cash Paid for Acquisition [Line Items]
Acquisition consideration		306,626
Share-based compensation expense		8,265
Total purchase price		$ 314,891